김태원 MD., PhD

by 관리자 posted Nov 18, 2015
?

단축키

Prev이전 문서

Next다음 문서

ESC닫기

크게 작게 위로 아래로 댓글로 가기 인쇄
Extra Form
소속 서울아산병원
기관명 서울아산병원 종양내과
전공 종양학/ 대장암
Extra Form
논문 Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Oncol (2015)

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
Lancet Oncol (2014)

p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN
Cell Death Differ (2014)

3'-Deoxy-3'-18F-Fluorothymidine PET for the Early Prediction of Response to Leucovorin, 5-Fluorouracil, and Oxaliplatin Therapy in Patients with Metastatic Colorectal Cancer
J Nucl Med (2013)

The MEK1/2 Inhibitor AS703026 Circumvents Resistance to the BRAF Inhibitor PLX4032 in Human Malignant Melanoma Cells.
Am J Med Sci (2013)

임상평가단장


Articles

1